Pharmaceutical SOPs – SOP Guide for Pharma https://www.pharmasop.in The Ultimate Resource for Pharmaceutical SOPs and Best Practices Thu, 12 Jun 2025 06:21:00 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.1 Creams: SOP for Ensuring Batch-to-Batch Consistency in Cream Manufacturing – V 2.0 https://www.pharmasop.in/creams-sop-for-ensuring-batch-to-batch-consistency-in-cream-manufacturing-v-2-0/ Thu, 12 Jun 2025 06:21:00 +0000 https://www.pharmasop.in/?p=9881 Read More “Creams: SOP for Ensuring Batch-to-Batch Consistency in Cream Manufacturing – V 2.0” »

]]>
Creams: SOP for Ensuring Batch-to-Batch Consistency in Cream Manufacturing – V 2.0

Standard Operating Procedure for Ensuring Batch-to-Batch Consistency in Cream Manufacturing

Department Creams
SOP No. SOP/CRM/148/2025
Supersedes SOP/CRM/148/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for ensuring batch-to-batch consistency in the manufacturing of cream products. Consistency across batches is essential for ensuring that each batch meets the required quality standards for texture, appearance, active ingredient content, and overall efficacy. This SOP outlines the necessary steps to monitor and control the manufacturing process to maintain uniformity in each batch of cream.

2. Scope

This SOP applies to all cream formulations manufactured at the facility. It covers the procedures for maintaining consistency in the production process, from ingredient sourcing to final product testing, to ensure uniformity in each batch.

3. Responsibilities

  • Production Team: Responsible for ensuring that manufacturing processes are consistently followed according to the formulation and batch records to maintain uniformity in every batch.
  • Quality Control (QC) Team: Responsible for performing quality tests on each batch to confirm that the batch meets the required specifications for uniformity and consistency.
  • Quality Assurance (QA) Team: Responsible for reviewing the batch records, testing results, and ensuring that any deviations from the expected quality are addressed and corrected.

4. Accountability

The QC Manager is accountable for ensuring that batch-to-batch consistency testing is performed in accordance with this SOP. The Production Supervisor is responsible for ensuring that manufacturing processes are consistently followed during production. The QA Manager is responsible for ensuring that the results of testing and manufacturing processes are reviewed and compliant with regulatory and internal standards.

5. Procedure

5.1 Pre-Manufacturing Activities

  1. Ensure that the formulation and batch records are accurate and up to date. Review the batch record to ensure that all ingredients and quantities are correctly listed and that the manufacturing process follows standard operating procedures (SOPs).
  2. Review the availability of raw materials to confirm that the quality and source of the ingredients remain consistent for each batch.
  3. Calibrate all necessary equipment, including mixing tanks, homogenizers, and filling machines, to ensure they are functioning properly and meet specifications for consistent production.

5.2 Manufacturing Process

  1. Follow the approved batch manufacturing process to ensure consistency in the mixing, blending, and homogenization of the cream formulation.
  2. Monitor key parameters such as mixing time, temperature, speed, and ingredient addition to ensure they remain consistent from batch to batch.
  3. Ensure that the correct quantities of ingredients are added as specified in the batch record. Use calibrated dispensing equipment to avoid deviations in the ingredient proportions.
  4. Maintain proper documentation of each production step, including temperature and pressure readings, to provide traceability and support consistency checks.

5.3 Quality Control Testing

  1. Perform routine quality control tests on each batch to ensure that the product meets the required specifications for consistency. These tests should include:
    • Active ingredient content
    • Viscosity
    • pH level
    • Appearance (color, texture)
    • Microbial contamination levels
  2. Compare the results from each batch to the specifications to identify any potential variations in the product’s quality.
  3. If the results from a batch are outside of the acceptable range, investigate the cause of the variation, which may include ingredient quality, equipment malfunction, or process deviation.

5.4 Batch-to-Batch Comparison

  1. At regular intervals, perform a batch-to-batch comparison of critical parameters such as active ingredient concentration, viscosity, and pH levels. This comparison ensures that the formulation remains consistent from one batch to the next.
  2. Review and document any differences observed between batches, and determine if these differences are within the acceptable limits or if corrective actions are necessary.
  3. Ensure that any deviations between batches are investigated, documented in the Deviation Log (Annexure-1), and corrective actions are taken to maintain consistency.

5.5 Post-Manufacturing Activities

  1. After production, complete all necessary batch records and quality control documentation, including testing results and any deviation reports.
  2. Submit the batch record and testing results for review and approval by the QA team to ensure that the batch meets all specifications and complies with GMP standards.
  3. If any deviations are observed, initiate corrective actions such as revising the formulation, improving manufacturing processes, or modifying equipment settings. Re-test the batch after implementing corrective actions.

5.6 Documentation and Record-Keeping

  1. Ensure that all batch production records, quality control test results, and deviation reports are complete, accurate, and securely stored. This includes the Batch Manufacturing Record (Annexure-1) and the Deviation Log (Annexure-2).
  2. Retain all records for a minimum of two years or as required by regulatory guidelines.
  3. Ensure that all documentation is reviewed and approved by the Quality Assurance team to verify compliance with GMP and regulatory standards.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment

7. Documents

  1. Annexure-1: Batch Manufacturing Record
  2. Annexure-2: Deviation Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • Pharmacopeial Monographs on Quality Control Testing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Batch Manufacturing Record

Batch Number Sample ID Manufacturing Date Viscosity (cP) pH Active Ingredient (%) Operator
12345 S-001 21/01/2026 2500 7.2 98.5% John Doe

Annexure-2: Deviation Log

Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
21/01/2026 12345 Active ingredient content below specification Adjusted formulation, reprocessed the batch Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
]]>
Creams: SOP for Dissolution Testing of Cream Products – V 2.0 https://www.pharmasop.in/creams-sop-for-dissolution-testing-of-cream-products-v-2-0/ Wed, 11 Jun 2025 13:51:00 +0000 https://www.pharmasop.in/?p=9880 Read More “Creams: SOP for Dissolution Testing of Cream Products – V 2.0” »

]]>
Creams: SOP for Dissolution Testing of Cream Products – V 2.0

Standard Operating Procedure for Dissolution Testing of Cream Products

Department Creams
SOP No. SOP/CRM/147/2025
Supersedes SOP/CRM/147/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to outline the procedure for conducting dissolution testing of cream products. Dissolution testing is performed to evaluate the release rate of active ingredients from cream formulations. This SOP ensures that the creams meet the required specifications for the controlled release of active ingredients, which is crucial for product efficacy and safety.

2. Scope

This SOP applies to all cream formulations that require dissolution testing to assess the release of active ingredients. It covers the procedures for preparing cream samples, performing dissolution testing, and recording the results for quality control and regulatory purposes.

3. Responsibilities

  • Production Team: Responsible for preparing the cream samples according to the formulation and batch record, ensuring the correct quantity and quality for dissolution testing.
  • Quality Control (QC) Team: Responsible for performing the dissolution tests on the cream samples and ensuring that the test results meet the required specifications.
  • Quality Assurance (QA) Team: Responsible for reviewing the dissolution test results and ensuring compliance with internal and regulatory requirements.

4. Accountability

The QC Manager is accountable for ensuring that dissolution testing is conducted in accordance with this SOP. The Production Supervisor is responsible for preparing the cream samples for dissolution testing. The QA Manager ensures that the test results are reviewed and approved in compliance with GMP and regulatory standards.

5. Procedure

5.1 Pre-Test Preparation

  1. Ensure that the necessary dissolution testing equipment is available, including dissolution apparatus (e.g., USP apparatus 2), temperature-controlled water bath, and calibrated pH meters.
  2. Review the batch record to confirm the formulation details and identify the active ingredients that need to be tested for dissolution.
  3. Prepare the cream samples according to the formulation and ensure they are properly homogenized and free from contamination.
  4. Label each sample with the batch number, sample ID, and test date for traceability during testing.

5.2 Dissolution Testing Procedure

  1. Set the dissolution apparatus to the required settings, including the specified temperature (typically 37°C ± 0.5°C) and appropriate rotation speed (typically 50-75 rpm).
  2. Place the cream sample into the dissolution vessel. If the cream is semi-solid, a small quantity should be carefully introduced to avoid disturbance during the test.
  3. Start the dissolution test by adding the required dissolution medium (e.g., phosphate buffer or water) to the vessel. Ensure that the medium is maintained at the correct volume and temperature throughout the test.
  4. At specified time intervals (e.g., 5, 10, 15, 30, 60 minutes), take aliquots from the dissolution medium for analysis of the active ingredient content.
  5. Ensure that the sample aliquots are properly filtered and analyzed using an appropriate analytical technique, such as HPLC or UV spectroscopy, to measure the active ingredient concentration in the dissolution medium.

5.3 Data Analysis and Interpretation

  1. Calculate the percentage of active ingredient released at each time point. Compare the results with the established specifications for the cream formulation, which may include a required release profile over time.
  2. If the release rate meets the specified criteria, mark the test as “Pass” in the Dissolution Testing Log (Annexure-1) and proceed with the next stage of production or release.
  3. If the release rate does not meet the specified criteria, mark the test as “Fail.” Investigate the potential causes of failure, such as improper sample preparation, equipment malfunction, or formulation issues.

5.4 Post-Test Activities

  1. Record all results, including batch number, sample ID, test date, active ingredient concentrations, and any deviations from the specifications, in the Dissolution Testing Log (Annexure-1).
  2. If the dissolution test fails, initiate corrective actions, such as re-formulating the product, adjusting the dissolution medium, or modifying the manufacturing process.
  3. Submit the test results for review and approval by the QA team to ensure compliance with internal and regulatory standards.

5.5 Documentation and Record-Keeping

  1. Ensure that all dissolution testing records are complete, accurate, and securely stored. This includes the Dissolution Testing Log (Annexure-1) and the Deviation Log (Annexure-2) for failed tests.
  2. Retain all records for a minimum of two years or as required by regulatory guidelines.
  3. Ensure that records are reviewed and approved by the Quality Assurance team to verify compliance with GMP standards and regulatory requirements.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment
  • HPLC: High-Performance Liquid Chromatography
  • USP: United States Pharmacopeia

7. Documents

  1. Annexure-1: Dissolution Testing Log
  2. Annexure-2: Deviation Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • United States Pharmacopeia (USP) Chapter <711> – Dissolution
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Dissolution Testing Log

Batch Number Sample ID Test Date Time (min) Release (%) Operator
12345 S-001 21/01/2026 10 25% John Doe
12345 S-001 21/01/2026 30 60% John Doe

Annexure-2: Deviation Log

Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
21/01/2026 12345 Release rate below specification Reformulated batch and adjusted testing parameters Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
]]>
Creams: SOP for Analytical Method Validation for Cream Testing – V 2.0 https://www.pharmasop.in/creams-sop-for-analytical-method-validation-for-cream-testing-v-2-0/ Tue, 10 Jun 2025 21:21:00 +0000 https://www.pharmasop.in/?p=9879 Read More “Creams: SOP for Analytical Method Validation for Cream Testing – V 2.0” »

]]>
Creams: SOP for Analytical Method Validation for Cream Testing – V 2.0

Standard Operating Procedure for Analytical Method Validation for Cream Testing

Department Creams
SOP No. SOP/CRM/146/2025
Supersedes SOP/CRM/146/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for the validation of analytical methods used in the testing of cream formulations. Analytical method validation ensures that the methods employed for testing the cream products are accurate, reliable, and suitable for their intended purpose. This SOP outlines the necessary steps to validate methods for parameters such as active ingredient content, pH, viscosity, and other critical quality attributes.

2. Scope

This SOP applies to all analytical methods used for testing cream formulations at the facility. It covers the procedures for validating methods for testing the physical, chemical, and microbiological properties of creams, ensuring that the methods meet regulatory requirements and internal quality standards.

3. Responsibilities

  • Production Team: Responsible for ensuring that the cream formulations are prepared according to the formulation and are available for testing during method validation studies.
  • Quality Control (QC) Team: Responsible for performing the validation of analytical methods, including sample testing and analysis. QC also ensures that methods are suitable for their intended use.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving the results of the method validation process to ensure that the methods meet internal and regulatory standards.

4. Accountability

The QC Manager is accountable for ensuring that all analytical methods are validated in accordance with this SOP. The Production Supervisor is responsible for ensuring that the formulations are available for testing during the validation process. The QA Manager ensures that the results of the validation process are reviewed and the methods are approved for use in routine testing.

5. Procedure

5.1 Pre-Validation Preparation

  1. Ensure that the necessary equipment for method validation is available, including calibrated laboratory instruments (e.g., spectrophotometers, pH meters, viscometers) and analytical reagents.
  2. Review the method to be validated, including its intended use, specifications, and any applicable regulatory guidelines (e.g., USP, EP, ICH).
  3. Ensure that a representative sample of the cream formulation is prepared for testing according to the validation protocol.
  4. Prepare the validation protocol, including objectives, parameters to be validated (e.g., specificity, precision, accuracy, linearity, range, robustness), and the criteria for acceptance.

5.2 Method Validation Testing

  1. Conduct method validation by testing the cream samples under various conditions to assess the reliability of the method. This may include performing tests at different concentrations, times, or temperatures.
  2. Validate parameters such as:
    • Specificity: Ensure that the method can accurately measure the active ingredient or other critical attributes without interference from other components in the formulation.
    • Precision: Test the method’s repeatability and reproducibility by performing multiple tests on the same sample under the same conditions.
    • Accuracy: Assess the method’s accuracy by comparing results obtained from the validated method with results from a reference or known method.
    • Linearity: Test the method’s ability to produce results that are directly proportional to the concentration of the sample within a specified range.
    • Range: Establish the concentration range within which the method is applicable and produces accurate and precise results.
    • Robustness: Assess the method’s ability to withstand small variations in experimental conditions (e.g., temperature, pH) without affecting the results.
  3. Record all test results, including any observations, deviations, or issues encountered during the validation process, in the Method Validation Log (Annexure-1).

5.3 Data Interpretation

  1. Analyze the results of the method validation to determine if the method meets the predefined acceptance criteria for each validated parameter.
  2. If the results meet the acceptance criteria, mark the method as validated and suitable for routine use in cream testing.
  3. If the results do not meet the criteria, investigate the cause of failure, make necessary adjustments to the method or process, and re-validate the method.

5.4 Post-Validation Activities

  1. Record all validation results, including pass/fail determinations, in the Method Validation Log (Annexure-1) and prepare a summary report.
  2. Submit the validation report for review and approval by the QA team to ensure compliance with regulatory and internal standards.
  3. If necessary, update the standard operating procedures (SOPs) and method protocols to incorporate the validated method.

5.5 Documentation and Record-Keeping

  1. Ensure that all method validation records are complete, accurate, and securely stored. This includes the Method Validation Log (Annexure-1) and the Deviation Log (Annexure-2) for failed validation attempts.
  2. Retain all records for a minimum of two years or as required by regulatory guidelines.
  3. Ensure that records are reviewed and approved by the Quality Assurance team to verify compliance with GMP standards and regulatory requirements.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment
  • HPLC: High-Performance Liquid Chromatography

7. Documents

  1. Annexure-1: Method Validation Log
  2. Annexure-2: Deviation Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • Pharmacopeial Monographs for Analytical Method Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Method Validation Log

Batch Number Sample ID Test Date Test Parameters Acceptance Criteria Test Result Operator
12345 S-001 21/01/2026 pH, Viscosity, Active Ingredient pH: 6.5-7.5, Viscosity: 2000-2500 cP, Active Ingredient: 98-102% Pass John Doe

Annexure-2: Deviation Log

Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
21/01/2026 12345 Viscosity out of specification Reformulated the batch, re-validated method Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
]]>
Creams: SOP for Determining Shelf Life of Cream Formulations – V 2.0 https://www.pharmasop.in/creams-sop-for-determining-shelf-life-of-cream-formulations-v-2-0/ Tue, 10 Jun 2025 04:51:00 +0000 https://www.pharmasop.in/?p=9878 Read More “Creams: SOP for Determining Shelf Life of Cream Formulations – V 2.0” »

]]>
Creams: SOP for Determining Shelf Life of Cream Formulations – V 2.0

Standard Operating Procedure for Determining Shelf Life of Cream Formulations

Department Creams
SOP No. SOP/CRM/145/2025
Supersedes SOP/CRM/145/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for determining the shelf life of cream formulations. Shelf life refers to the period during which a product remains safe, stable, and effective for use. This SOP ensures that cream formulations are subjected to stability testing, allowing for accurate determination of their shelf life under different storage conditions.

2. Scope

This SOP applies to all cream formulations produced at the facility. It includes the procedures for performing stability studies to determine the shelf life of cream products, including temperature, humidity, and light exposure testing.

3. Responsibilities

  • Production Team: Responsible for ensuring that the cream formulations are prepared according to the specified formulation and batch record, and that they are sent for stability testing in the required conditions.
  • Quality Control (QC) Team: Responsible for performing stability testing under the specified storage conditions and ensuring that the samples are tested at the required intervals.
  • Quality Assurance (QA) Team: Responsible for reviewing the stability testing results, ensuring that the product meets the required specifications, and determining the final shelf life based on the test results.

4. Accountability

The QC Manager is accountable for ensuring that stability testing is conducted in accordance with this SOP. The Production Supervisor is responsible for ensuring that the cream formulations are prepared according to the formulation and sent for stability testing. The QA Manager ensures that the test results are reviewed and the shelf life is approved in compliance with GMP and regulatory standards.

5. Procedure

5.1 Pre-Test Preparation

  1. Ensure that the necessary equipment and testing materials for stability studies are available, including stability chambers, temperature and humidity controls, and sample containers that meet regulatory requirements.
  2. Review the batch record to confirm the formulation details and identify the specific storage conditions for the stability study (e.g., room temperature, accelerated conditions, or refrigerated conditions).
  3. Prepare the cream samples according to the formulation and ensure that each batch is prepared in a consistent manner.
  4. Label each sample with the batch number, sample ID, testing start date, and any other relevant details to ensure traceability during testing.

5.2 Stability Testing Procedure

  1. Place the cream samples in the stability chamber, ensuring that the conditions (temperature, humidity, and light) are set according to the defined study parameters.
  2. Conduct stability testing at different intervals (e.g., 0 months, 1 month, 3 months, 6 months, 12 months) as per the required study protocol.
  3. For each interval, test the cream samples for relevant physical, chemical, and microbiological properties, such as pH, viscosity, appearance, odor, microbial load, and active ingredient content.
  4. Record the results of each test, including the date of testing and any observations related to changes in the product, in the Stability Testing Log (Annexure-1).

5.3 Interpretation of Results

  1. Compare the results from each testing interval with the initial sample’s baseline results to determine if there is any degradation, change in appearance, or loss of active ingredient concentration.
  2. If the product shows no significant changes in its physical and chemical properties within the specified shelf life, the cream is considered stable for the duration of the study.
  3. If the product exhibits significant changes (e.g., changes in pH, viscosity, or microbial contamination), investigate the cause of instability and take corrective actions. Mark the test as “Fail” in the Stability Testing Log (Annexure-1).
  4. Based on the results, determine the maximum shelf life and storage conditions for the cream formulation.

5.4 Post-Test Activities

  1. Record all results in the Stability Testing Log (Annexure-1), including batch number, sample ID, and test dates for each interval.
  2. If the stability test fails, initiate corrective actions, such as adjusting the formulation or improving the manufacturing process. Re-test the sample after corrective actions.
  3. Submit the test results for review and approval by the QA team, and update the product’s shelf life based on the stability study results.

5.5 Documentation and Record-Keeping

  1. Ensure that all stability testing records are complete, accurate, and securely stored. This includes the Stability Testing Log (Annexure-1) and the Deviation Log (Annexure-2) for failed tests.
  2. Retain all records for a minimum of two years or as required by regulatory guidelines.
  3. Ensure that records are reviewed and approved by the Quality Assurance team to verify compliance with GMP standards and regulatory requirements.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment

7. Documents

  1. Annexure-1: Stability Testing Log
  2. Annexure-2: Deviation Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • Pharmacopeial Monographs for Stability Testing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Stability Testing Log

Batch Number Sample ID Test Date pH Viscosity Appearance Microbial Load Active Ingredient Content (%) Operator
12345 S-001 21/01/2026 7.4 2500 cP Clear Pass 98.5% John Doe

Annexure-2: Deviation Log

Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
21/01/2026 12345 Viscosity exceeded specification Reformulated the batch, adjusted the mixing process Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
]]>
Creams: SOP for Ensuring Homogeneity in Cream Batches – V 2.0 https://www.pharmasop.in/creams-sop-for-ensuring-homogeneity-in-cream-batches-v-2-0/ Mon, 09 Jun 2025 12:21:00 +0000 https://www.pharmasop.in/?p=9877 Read More “Creams: SOP for Ensuring Homogeneity in Cream Batches – V 2.0” »

]]>
Creams: SOP for Ensuring Homogeneity in Cream Batches – V 2.0

Standard Operating Procedure for Ensuring Homogeneity in Cream Batches

Department Creams
SOP No. SOP/CRM/144/2025
Supersedes SOP/CRM/144/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for ensuring homogeneity in cream batches. Homogeneity in cream formulations ensures uniform distribution of active ingredients, excipients, and other components throughout the batch. This SOP ensures that the cream products meet quality specifications, providing consistent texture, efficacy, and safety for the end consumer.

2. Scope

This SOP applies to all cream formulations produced at the facility. It covers the process of ensuring that cream formulations are thoroughly mixed during production to maintain uniformity in ingredient distribution, both for the active ingredients and excipients.

3. Responsibilities

  • Production Team: Responsible for ensuring that the mixing process is carried out properly and that the equipment is functioning to achieve a homogeneous mixture.
  • Quality Control (QC) Team: Responsible for verifying the homogeneity of the batch through sampling and testing to confirm that the cream meets the required specifications.
  • Quality Assurance (QA) Team: Responsible for reviewing the results of homogeneity testing and ensuring compliance with internal specifications and regulatory requirements.

4. Accountability

The QC Manager is accountable for ensuring that homogeneity testing is performed in accordance with this SOP. The Production Supervisor is responsible for ensuring that the cream formulations are uniformly mixed during production. The QA Manager ensures that the test results are reviewed and approved in compliance with GMP and regulatory standards.

5. Procedure

5.1 Pre-Test Preparation

  1. Ensure that the necessary equipment for testing homogeneity is available, including a calibrated laboratory balance, a mixing machine, and a sample collection kit.
  2. Ensure that the batch record has been reviewed to confirm that all ingredients and formulation details are correct, and to identify the appropriate testing method for homogeneity.
  3. Prepare the necessary calibration standards or reference materials if needed, and ensure that all equipment is in proper working condition before starting the production process.

5.2 Mixing Process

  1. Ensure that the cream is mixed according to the established formulation procedures, with specific attention to achieving uniform distribution of all ingredients.
  2. Monitor the mixing speed and time to ensure that it falls within the optimal range for achieving homogeneity. Typically, mixing should be conducted at a consistent speed for a specified time to ensure complete blending.
  3. Ensure that all mixing equipment (e.g., planetary mixers, homogenizers) is calibrated and functioning properly before use.

5.3 Sampling for Homogeneity Testing

  1. Collect representative samples from different areas of the batch, including the top, middle, and bottom sections, to ensure accurate representation of the entire batch.
  2. Label each sample with the batch number, sample ID, sampling date, and other relevant details to ensure traceability during testing.
  3. Ensure that the sample is taken using proper aseptic techniques to prevent contamination and preserve homogeneity.

5.4 Homogeneity Testing Procedure

  1. Weigh each sample using a calibrated laboratory balance to ensure the correct quantity for testing.
  2. Test the samples for uniformity of content, checking the concentration of active ingredients and excipients. This can be done using techniques such as HPLC, UV-Visible spectrophotometry, or other appropriate analytical methods.
  3. Perform testing for each sample in triplicate to ensure consistency and reliability of the results.
  4. Record the results of each test, including the measured concentration of each active ingredient and any deviations from the expected content, in the Homogeneity Testing Log (Annexure-1).

5.5 Interpretation of Results

  1. Compare the results of the homogeneity tests with the established specifications for the batch. The concentration of the active ingredients and excipients should be within the specified range to ensure uniformity.
  2. If the test results show that the sample is within the acceptable range, mark the test as “Pass” in the Homogeneity Testing Log (Annexure-1) and proceed with the next stage of production or release.
  3. If the test results show that the sample is outside the acceptable range, mark the test as “Fail.” Investigate the cause of the variation, which may include improper mixing, incorrect formulation, or equipment malfunction.

5.6 Post-Test Activities

  1. Record all test results, including batch number, sample ID, test date, and any corrective actions taken in the Homogeneity Testing Log (Annexure-1).
  2. If the homogeneity test fails, initiate corrective actions such as adjusting the formulation, improving mixing techniques, or reprocessing the batch to ensure homogeneity. Re-test the sample after corrective actions.
  3. Submit the test results for review and approval by the QA team to ensure compliance with internal and regulatory standards.

5.7 Documentation and Record-Keeping

  1. Ensure that all homogeneity testing records are complete, accurate, and securely stored. This includes the Homogeneity Testing Log (Annexure-1) and the Deviation Log (Annexure-2) for failed tests.
  2. Retain all records for a minimum of two years or as required by regulatory guidelines.
  3. Ensure that records are reviewed and approved by the Quality Assurance team to verify compliance with GMP standards and regulatory requirements.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment
  • HPLC: High-Performance Liquid Chromatography

7. Documents

  1. Annexure-1: Homogeneity Testing Log
  2. Annexure-2: Deviation Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • Pharmacopeial Monographs on Uniformity of Content and Mixing Procedures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Homogeneity Testing Log

Batch Number Sample ID Test Date Active Ingredient Content (%) Operator
12345 S-001 21/01/2026 98.5% John Doe

Annexure-2: Deviation Log

Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
21/01/2026 12345 Active ingredient content out of specification Reformulated and re-tested Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
]]>
Creams: SOP for Allergen Testing in Cream Products – V 2.0 https://www.pharmasop.in/creams-sop-for-allergen-testing-in-cream-products-v-2-0/ Sun, 08 Jun 2025 03:21:00 +0000 https://www.pharmasop.in/?p=9875 Read More “Creams: SOP for Allergen Testing in Cream Products – V 2.0” »

]]>
Creams: SOP for Allergen Testing in Cream Products – V 2.0

Standard Operating Procedure for Allergen Testing in Cream Products

Department Creams
SOP No. SOP/CRM/143/2025
Supersedes SOP/CRM/143/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for allergen testing in cream products. Allergens present in cosmetics can cause allergic reactions, making their presence and concentration a significant safety concern. This SOP ensures that cream products are tested for common allergens to meet regulatory standards and protect consumer health.

2. Scope

This SOP applies to all cream formulations produced at the facility, especially those intended for direct consumer use. It includes procedures for testing the cream products for the presence of allergens during the production process and before the final product release.

3. Responsibilities

  • Production Team: Responsible for ensuring that cream formulations are prepared in compliance with allergen safety guidelines and for ensuring that all ingredients used are compliant with allergen testing standards.
  • Quality Control (QC) Team: Responsible for conducting allergen testing and ensuring that the test results meet the regulatory and internal specifications for allergen content.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving the results of allergen testing to ensure compliance with internal specifications and regulatory requirements.

4. Accountability

The QC Manager is accountable for ensuring that allergen testing is performed in accordance with this SOP. The Production Supervisor is responsible for ensuring that the cream formulations are produced according to allergen safety guidelines. The QA Manager ensures that the test results are reviewed and approved in compliance with GMP and regulatory standards.

5. Procedure

5.1 Pre-Test Preparation

  1. Ensure that the necessary equipment for allergen testing is available, including suitable test kits (e.g., ELISA kits) and a properly calibrated laboratory balance for sample preparation.
  2. Prepare the necessary reagents and calibration standards according to the testing method. Use certified reference materials (CRMs) for allergen calibration.
  3. Review the batch record to confirm the formulation details, including the ingredients used, and identify potential allergens that need to be tested for.

5.2 Sample Collection

  1. Collect a representative sample of the finished cream product. Ensure the sample is homogeneous and free from contamination.
  2. Label each sample with the batch number, sample ID, sampling date, and other relevant details to ensure traceability during testing.
  3. Ensure that the sample is taken from sealed containers to maintain the integrity of the formulation and prevent cross-contamination during testing.

5.3 Allergen Testing Procedure

  1. Prepare the sample for allergen testing by following the manufacturer’s instructions for the specific test method (e.g., ELISA or PCR for allergens such as peanuts, tree nuts, dairy, gluten, etc.).
  2. Perform the allergen test in triplicate to ensure consistency and reliability of the results. The sample should be prepared and tested under controlled conditions to avoid contamination.
  3. Record the allergen content results for each test sample, noting the concentration of each allergen tested, in the Allergen Testing Log (Annexure-1).

5.4 Interpretation of Results

  1. Compare the allergen test results with the specified limits for each allergen. The permissible levels for allergens are typically defined by regulatory agencies (e.g., FDA, EMA) and should be within the thresholds established for consumer safety.
  2. For example, the FDA recommends that the maximum allowable concentration for peanuts or other allergens in cosmetics should be non-detectable or below the threshold level for allergic reactions.
  3. If the test results show that the allergen concentration is within the acceptable range, mark the test as “Pass” in the Allergen Testing Log (Annexure-1) and proceed with the next stage of production or release.
  4. If the test results show that the allergen concentration exceeds the specified limit, mark the test as “Fail.” Investigate the source of the contamination, which may include ingredients, equipment contamination, or cross-contamination during production.

5.5 Post-Test Activities

  1. Record all test results, including batch number, sample ID, allergen concentrations, and any corrective actions taken, in the Allergen Testing Log (Annexure-1).
  2. If the allergen test fails, initiate corrective actions such as revisiting the sourcing of ingredients, revising the formulation, or improving production processes to ensure that allergens are minimized or removed. Re-test the sample after corrective actions.
  3. Submit the test results for review and approval by the QA team to ensure compliance with internal and regulatory standards.

5.6 Documentation and Record-Keeping

  1. Ensure that all allergen testing records are complete, accurate, and securely stored. This includes the Allergen Testing Log (Annexure-1) and the Deviation Log (Annexure-2) for failed tests.
  2. Retain all records for a minimum of two years or as required by regulatory guidelines.
  3. Ensure that records are reviewed and approved by the Quality Assurance team to verify compliance with GMP standards and regulatory requirements.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment
  • ELISA: Enzyme-Linked Immunosorbent Assay

7. Documents

  1. Annexure-1: Allergen Testing Log
  2. Annexure-2: Deviation Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • FDA Guidelines for Allergen Testing in Cosmetics
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Allergen Testing Log

Batch Number Sample ID Test Date Allergen Concentration (ppm) Operator
12345 S-001 21/01/2026 Peanuts: 0 ppm, Gluten: 0.2 ppm John Doe

Annexure-2: Deviation Log

Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
21/01/2026 12345 Gluten content exceeded permissible limits Re-sourced raw material, reprocessed the batch Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
]]>
Creams: SOP for Conducting Heavy Metal Testing in Creams – V 2.0 https://www.pharmasop.in/creams-sop-for-conducting-heavy-metal-testing-in-creams-v-2-0/ Sat, 07 Jun 2025 10:51:00 +0000 https://www.pharmasop.in/?p=9874 Read More “Creams: SOP for Conducting Heavy Metal Testing in Creams – V 2.0” »

]]>
Creams: SOP for Conducting Heavy Metal Testing in Creams – V 2.0

Standard Operating Procedure for Conducting Heavy Metal Testing in Creams

Department Creams
SOP No. SOP/CRM/142/2025
Supersedes SOP/CRM/142/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for conducting heavy metal testing in cream formulations. Heavy metals, such as lead, arsenic, cadmium, and mercury, can be toxic even at low concentrations, making their presence in cosmetic products a critical quality and safety concern. This SOP ensures that creams are tested for heavy metals to meet regulatory standards and protect consumer health.

2. Scope

This SOP applies to all cream formulations produced at the facility, particularly those intended for direct consumer use. It includes procedures for testing cream samples for the presence of heavy metals during the production process and after the formulation is completed.

3. Responsibilities

  • Production Team: Responsible for ensuring that the cream formulations are prepared according to established specifications, with careful handling of ingredients to minimize contamination from heavy metals.
  • Quality Control (QC) Team: Responsible for conducting heavy metal testing and ensuring that the test results meet regulatory requirements for heavy metal content in cream formulations.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving the results of heavy metal testing to ensure compliance with internal specifications and regulatory standards.

4. Accountability

The QC Manager is accountable for ensuring that heavy metal testing is performed in accordance with this SOP. The Production Supervisor is responsible for ensuring that the cream formulations are produced according to the established specifications to minimize contamination. The QA Manager ensures that the test results are reviewed and approved in compliance with GMP and regulatory standards.

5. Procedure

5.1 Pre-Test Preparation

  1. Ensure that the necessary equipment for heavy metal testing is available, including an atomic absorption spectrophotometer (AAS), inductively coupled plasma mass spectrometer (ICP-MS), or any other suitable instruments for detecting heavy metals in cream formulations.
  2. Prepare the necessary reagents and calibration standards according to the testing method. Use certified reference materials (CRMs) for calibration.
  3. Review the batch record to confirm the ingredients used in the cream formulation and ensure that they meet safety standards with regard to heavy metal content.

5.2 Sample Collection

  1. Collect a representative sample of the finished cream formulation for heavy metal testing. Ensure the sample is homogenous and free from contamination.
  2. Label each sample with the batch number, sample ID, sampling date, and other relevant details to ensure traceability during testing.
  3. Ensure that the sample is taken from sealed containers to maintain the integrity of the formulation and prevent contamination during testing.

5.3 Heavy Metal Testing Procedure

  1. Prepare the sample for testing by diluting or digesting the cream formulation as required by the testing method. Follow the manufacturer’s instructions for sample preparation.
  2. Perform the heavy metal test using the appropriate method (e.g., AAS, ICP-MS, or others) to detect and quantify heavy metals such as lead, arsenic, cadmium, and mercury in the cream sample.
  3. For each sample, perform the test in triplicate to ensure consistency and reliability of the results.
  4. Record the results of the heavy metal test, including the concentration of each detected heavy metal, in the Heavy Metal Testing Log (Annexure-1).

5.4 Interpretation of Results

  1. Compare the results of the heavy metal testing with the specified limits for each heavy metal. The acceptable limits for heavy metals are typically defined by regulatory agencies (e.g., FDA, EMA) and should be within the permissible thresholds.
  2. For example, the FDA specifies that the maximum allowable concentration for lead in cosmetic products should be less than 10 ppm (parts per million).
  3. If the heavy metal concentrations are within the acceptable range, mark the test as “Pass” in the Heavy Metal Testing Log (Annexure-1) and proceed with the next stage of production or release.
  4. If the heavy metal concentrations exceed the specified limits, mark the test as “Fail.” Investigate the cause of the contamination, which may include ingredient sourcing, equipment contamination, or improper handling practices.

5.5 Post-Test Activities

  1. Record all test results, including batch number, sample ID, heavy metal concentrations, and any corrective actions taken, in the Heavy Metal Testing Log (Annexure-1).
  2. If the heavy metal test fails, initiate corrective actions, such as revisiting the sourcing of ingredients, reworking the batch, or adjusting the formulation to minimize heavy metal contamination. Re-test the sample after corrective actions.
  3. Submit the test results for review and approval by the QA team to ensure compliance with internal and regulatory standards.

5.6 Documentation and Record-Keeping

  1. Ensure that all heavy metal testing records are complete, accurate, and securely stored. This includes the Heavy Metal Testing Log (Annexure-1) and the Deviation Log (Annexure-2) for failed tests.
  2. Retain all records for a minimum of two years or as required by regulatory guidelines.
  3. Ensure that records are reviewed and approved by the Quality Assurance team to verify compliance with GMP standards and regulatory requirements.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment
  • AAS: Atomic Absorption Spectrophotometry
  • ICP-MS: Inductively Coupled Plasma Mass Spectrometry

7. Documents

  1. Annexure-1: Heavy Metal Testing Log
  2. Annexure-2: Deviation Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • FDA Guidelines for Heavy Metals in Cosmetics
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Heavy Metal Testing Log

Batch Number Sample ID Test Date Heavy Metal Concentration (ppm) Operator
12345 S-001 21/01/2026 Lead: 2 ppm, Arsenic: 0.5 ppm John Doe

Annexure-2: Deviation Log

Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
21/01/2026 12345 Lead content exceeded permissible limits Re-sourced raw material, reprocessed the batch Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
]]>
Creams: SOP for Ensuring Uniformity of Content in Creams – V 2.0 https://www.pharmasop.in/creams-sop-for-ensuring-uniformity-of-content-in-creams-v-2-0/ Fri, 06 Jun 2025 18:21:00 +0000 https://www.pharmasop.in/?p=9873 Read More “Creams: SOP for Ensuring Uniformity of Content in Creams – V 2.0” »

]]>
Creams: SOP for Ensuring Uniformity of Content in Creams – V 2.0

Standard Operating Procedure for Ensuring Uniformity of Content in Creams

Department Creams
SOP No. SOP/CRM/141/2025
Supersedes SOP/CRM/141/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for ensuring the uniformity of content in cream formulations. Uniformity of content is crucial for consistent product quality, ensuring that each batch of cream contains the correct proportions of active ingredients and excipients. This SOP ensures that the distribution of components in the cream is consistent across each batch.

2. Scope

This SOP applies to all cream formulations produced at the facility. It covers the processes involved in verifying and ensuring the uniformity of active ingredients, excipients, and other critical components in cream batches, both during production and after filling.

3. Responsibilities

  • Production Team: Responsible for ensuring that the cream formulation is mixed and processed uniformly during production. They are also responsible for providing representative samples for uniformity testing.
  • Quality Control (QC) Team: Responsible for conducting uniformity of content testing and ensuring that the test results meet the required specifications.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving the results of the uniformity of content tests to ensure compliance with internal specifications and regulatory requirements.

4. Accountability

The QC Manager is accountable for ensuring that uniformity of content testing is performed according to this SOP. The Production Supervisor is responsible for ensuring that the cream formulations are uniformly mixed during production. The QA Manager ensures that the test results are reviewed and approved in compliance with GMP and regulatory standards.

5. Procedure

5.1 Pre-Test Preparation

  1. Ensure that the necessary equipment for content uniformity testing is available, including a suitable laboratory balance for accurate measurements, and sampling tools for obtaining representative samples from the cream batch.
  2. Ensure that all necessary reagents and solvents are prepared for use in the analysis, including the correct concentration for any active ingredients or preservatives.
  3. Review the batch record to confirm the formulation details and the specified uniformity requirements for the active ingredients and excipients.

5.2 Sample Collection

  1. Collect representative samples from different parts of the batch, including the top, middle, and bottom sections of the cream container to ensure an accurate representation of the entire batch.
  2. Ensure that the samples are taken using proper aseptic techniques to prevent contamination and maintain uniformity.
  3. Label each sample with the batch number, sample ID, sampling date, and other relevant details to ensure traceability during testing.

5.3 Uniformity of Content Testing Procedure

  1. Weigh each sample using a calibrated laboratory balance to ensure the correct quantity is used for analysis.
  2. Analyze the active ingredient(s) in each sample using a validated method (e.g., HPLC, UV-Visible spectrophotometry) to quantify the concentration of the active ingredient and verify that it is within the specified limits.
  3. Perform testing for each sample in triplicate to ensure consistency and reliability of the results.
  4. Record the results of each test, including the measured concentration of the active ingredient(s) and any variations from the expected content, in the Uniformity of Content Testing Log (Annexure-1).

5.4 Interpretation of Results

  1. Compare the results of the uniformity of content test with the established specifications for content uniformity. The content of the active ingredient(s) should fall within the acceptable range, which is typically within ±10% of the nominal content.
  2. If the test results show that the content is within the specified range, mark the test as “Pass” in the Uniformity of Content Testing Log (Annexure-1) and proceed with the next stage of production or release.
  3. If the test results show that the content is outside the acceptable range, mark the test as “Fail.” Investigate the cause of the failure, which may include inadequate mixing, incorrect formulation, or insufficient homogenization.

5.5 Post-Test Activities

  1. Record all test results, including batch number, sample ID, test date, content uniformity results, and any corrective actions taken in the Uniformity of Content Testing Log (Annexure-1).
  2. If the uniformity of content test fails, initiate corrective actions such as adjusting the formulation, improving mixing techniques, or reprocessing the batch to ensure content uniformity. Re-test the sample after corrective actions.
  3. Submit the test results for review and approval by the QA team to ensure compliance with internal and regulatory standards.

5.6 Documentation and Record-Keeping

  1. Ensure that all uniformity of content testing records are complete, accurate, and securely stored. This includes the Uniformity of Content Testing Log (Annexure-1) and the Deviation Log (Annexure-2) for failed tests.
  2. Retain all records for a minimum of two years or as required by regulatory guidelines.
  3. Ensure that records are reviewed and approved by the Quality Assurance team to verify compliance with GMP standards and regulatory requirements.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment

7. Documents

  1. Annexure-1: Uniformity of Content Testing Log
  2. Annexure-2: Deviation Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • Pharmacopeial Monographs for Uniformity of Content Testing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Uniformity of Content Testing Log

Batch Number Sample ID Test Date Active Ingredient Content (%) Operator
12345 S-001 21/01/2026 98.5% John Doe

Annexure-2: Deviation Log

Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
21/01/2026 12345 Active ingredient content out of specification Reprocessed and re-tested Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
]]>
Creams: SOP for Particle Size Analysis in Cream Emulsions – V 2.0 https://www.pharmasop.in/creams-sop-for-particle-size-analysis-in-cream-emulsions-v-2-0/ Fri, 06 Jun 2025 01:51:00 +0000 https://www.pharmasop.in/?p=9872 Read More “Creams: SOP for Particle Size Analysis in Cream Emulsions – V 2.0” »

]]>
Creams: SOP for Particle Size Analysis in Cream Emulsions – V 2.0

Standard Operating Procedure for Particle Size Analysis in Cream Emulsions

Department Creams
SOP No. SOP/CRM/140/2025
Supersedes SOP/CRM/140/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for performing particle size analysis of cream emulsions. Particle size plays a critical role in the stability, texture, and performance of cream products. This test ensures that the particle size distribution is within the desired range to meet the product specifications and optimize its quality.

2. Scope

This SOP applies to all cream emulsions produced at the facility. It covers the process for measuring and analyzing the particle size of emulsions both during the formulation process and in the finished cream products.

3. Responsibilities

  • Production Team: Responsible for ensuring that the cream emulsions are correctly prepared and that the desired particle size specifications are achieved during formulation.
  • Quality Control (QC) Team: Responsible for conducting particle size analysis and ensuring that the results meet the specified requirements.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving the results of the particle size analysis to ensure compliance with internal specifications and regulatory standards.

4. Accountability

The QC Manager is accountable for ensuring that particle size analysis is performed in accordance with this SOP. The Production Supervisor is responsible for providing the representative samples for testing. The QA Manager ensures that the test results are reviewed and approved in compliance with GMP and regulatory standards.

5. Procedure

5.1 Pre-Test Preparation

  1. Ensure that the necessary equipment for particle size analysis is available, including a laser diffraction analyzer, particle size analyzer, or any other suitable instruments for measurement.
  2. Calibrate the particle size analyzer according to the manufacturer’s instructions to ensure accurate measurements.
  3. Review the batch record to confirm the formulation details, including the type of emulsifier and stabilizer used, and the intended particle size distribution for the cream emulsion.

5.2 Sample Collection

  1. Collect a representative sample of the cream emulsion from the finished batch. The sample should be homogenous and free from contamination.
  2. Label the sample with the batch number, sample ID, sampling date, and other relevant details to ensure traceability during testing.
  3. Ensure that the sample is collected from sealed containers to maintain the integrity of the emulsion and prevent contamination during testing.

5.3 Particle Size Analysis Procedure

  1. Place the sample into the particle size analyzer. If necessary, dilute the sample with an appropriate solvent to achieve optimal concentration for analysis.
  2. Set the analyzer to the appropriate particle size measurement mode (e.g., laser diffraction, dynamic light scattering) and initiate the measurement procedure.
  3. Conduct at least three measurements for each sample to ensure consistency. The measurements should be performed at different time intervals if required (e.g., initial, after emulsification, and after storage).
  4. Record the particle size distribution, including the mean particle size, median size, and span (a measure of the width of the size distribution) in the Particle Size Analysis Log (Annexure-1).

5.4 Interpretation of Results

  1. Review the particle size distribution results, ensuring that the particle size is within the specified range for the cream formulation. Typically, emulsions with smaller particle sizes (less than 10 microns) are preferred for smooth texture and stability.
  2. Acceptable particle size distribution is defined by the specification for the specific formulation. If the particle size is outside the acceptable range, mark the result as “Fail.”
  3. If the test fails, investigate potential causes such as improper emulsification, insufficient mixing, or incorrect formulation components, and perform corrective actions as necessary.
  4. Record all deviations, investigations, and corrective actions in the Particle Size Analysis Log (Annexure-1) and submit the results for further review.

5.5 Post-Test Activities

  1. Record all test results, including batch number, sample ID, particle size distribution, and any corrective actions taken, in the Particle Size Analysis Log (Annexure-1).
  2. If the particle size is found to be out of specification, initiate corrective actions such as reprocessing the emulsion or modifying the formulation, and re-test after corrective actions.
  3. Submit the test results for review and approval by the QA team to ensure compliance with internal and regulatory standards.

5.6 Documentation and Record-Keeping

  1. Ensure that all particle size analysis records are complete, accurate, and securely stored. This includes the Particle Size Analysis Log (Annexure-1) and the Deviation Log (Annexure-2) for failed tests.
  2. Retain all records for a minimum of two years or as required by regulatory guidelines.
  3. Ensure that records are reviewed and approved by the Quality Assurance team to verify compliance with GMP standards and regulatory requirements.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment
  • μm: Micrometer (used for particle size)

7. Documents

  1. Annexure-1: Particle Size Analysis Log
  2. Annexure-2: Deviation Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • ISO 13320 – Particle Size Analysis – Laser Diffraction Methods
  • International Pharmaceutical Excipients Council (IPEC) Guidelines on Emulsion Formulations

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Particle Size Analysis Log

Batch Number Sample ID Test Date Particle Size (μm) Operator
12345 S-001 21/01/2026 5.2 John Doe

Annexure-2: Deviation Log

Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
21/01/2026 12345 Particle size out of specification Reformulated and re-tested Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
]]>
Creams: SOP for Odor Stability Testing in Cream Formulations – V 2.0 https://www.pharmasop.in/creams-sop-for-odor-stability-testing-in-cream-formulations-v-2-0/ Thu, 05 Jun 2025 09:21:00 +0000 https://www.pharmasop.in/?p=9871 Read More “Creams: SOP for Odor Stability Testing in Cream Formulations – V 2.0” »

]]>
Creams: SOP for Odor Stability Testing in Cream Formulations – V 2.0

Standard Operating Procedure for Odor Stability Testing in Cream Formulations

Department Creams
SOP No. SOP/CRM/139/2025
Supersedes SOP/CRM/139/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for odor stability testing of cream formulations. Odor is a key sensory attribute for cosmetic products, and it must remain stable throughout the product’s shelf life. This test ensures that the fragrance or odor of the cream does not degrade or develop off-odors during storage or usage.

2. Scope

This SOP applies to all cream formulations produced at the facility, specifically focusing on testing the stability of odor characteristics during long-term and accelerated storage conditions.

3. Responsibilities

  • Production Team: Responsible for preparing the cream formulations in accordance with established specifications and ensuring that samples are representative of the entire batch.
  • Quality Control (QC) Team: Responsible for conducting odor stability tests and ensuring the product maintains its intended odor characteristics throughout its shelf life.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving the results of odor stability tests to ensure that the product meets internal quality standards and regulatory requirements.

4. Accountability

The QC Manager is accountable for ensuring that odor stability testing is performed according to this SOP. The Production Supervisor is responsible for providing the representative samples for testing. The QA Manager ensures that the test results are reviewed and approved in compliance with GMP and regulatory standards.

5. Procedure

5.1 Pre-Test Preparation

  1. Ensure that the necessary equipment for odor stability testing is available, including properly ventilated sample containers, odor-neutral environments, and any required testing instruments (e.g., olfactometers for objective assessment).
  2. Review the batch record to confirm the ingredients used in the cream formulation and the expected fragrance or odor profile of the product.
  3. Ensure the availability of trained panelists or assessors who can evaluate the odor characteristics during the test period.

5.2 Sample Collection

  1. Collect representative samples of the cream formulation at different time points, including freshly produced cream and samples at intervals during stability testing (e.g., 0, 7, 14, 21, and 28 days).
  2. Label each sample with the batch number, sample ID, sampling date, and storage conditions to ensure traceability during testing.
  3. Ensure that the samples are taken from sealed containers to maintain the integrity of the product’s odor profile.

5.3 Odor Stability Testing Procedure

  1. Place the cream samples under specified storage conditions for accelerated stability (e.g., elevated temperature and humidity) or long-term storage (e.g., 25°C, 60% RH).
  2. At each specified time point, open the sample container and allow the odor to stabilize in a controlled environment.
  3. Conduct odor evaluations using a trained panel of assessors or using an olfactometer. The panel should assess the odor intensity, quality, and any changes in the fragrance over time.
  4. Record the odor evaluation results using a sensory evaluation sheet or other suitable documentation methods. The panelists should note any changes in odor, such as degradation or off-odors.
  5. For objective measurements, an olfactometer can be used to quantify odor intensity. This can provide a more standardized approach for odor stability assessment.

5.4 Interpretation of Results

  1. Compare the odor characteristics at each time point with the initial sample’s odor profile. A significant change in odor (e.g., unpleasant or off-odors) indicates a failure in odor stability.
  2. Record any deviations or changes in odor in the Odor Stability Test Log (Annexure-1). If the sample passes the test, mark the result as “Pass.” If it fails, mark the result as “Fail.”
  3. If a failure occurs, investigate the cause of the odor degradation, which may include improper formulation, unstable ingredients, or poor storage conditions.

5.5 Post-Test Activities

  1. Record all test results, including batch number, sample ID, time points, odor evaluation results, and any corrective actions taken in the Odor Stability Test Log (Annexure-1).
  2. If a sample fails the test, initiate corrective actions, such as reformulating the cream, adjusting the preservative system, or modifying storage conditions. Re-test the sample after corrective actions.
  3. Submit the test results for review and approval by the QA team to ensure compliance with internal and regulatory standards.

5.6 Documentation and Record-Keeping

  1. Ensure that all odor stability testing records are complete, accurate, and securely stored. This includes the Odor Stability Test Log (Annexure-1) and the Deviation Log (Annexure-2) for failed tests.
  2. Retain all records for a minimum of two years or as required by regulatory guidelines.
  3. Ensure that records are reviewed and approved by the Quality Assurance team to verify compliance with GMP standards and regulatory requirements.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment

7. Documents

  1. Annexure-1: Odor Stability Test Log
  2. Annexure-2: Deviation Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • ISO 9001 – Quality Management Systems

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Odor Stability Test Log

Batch Number Sample ID Test Date Odor Evaluation (Intensity/Description) Operator
12345 S-001 21/01/2026 Pass (No off-odor, stable fragrance) John Doe

Annexure-2: Deviation Log

Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
21/01/2026 12345 Off-odor detected in sample after 14 days Reformulated, re-tested Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
]]>